Company / Interest Expense
Bio-Rad Laboratories Interest Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$49.0M
FY2025
5-year range
$1.6M / $49.4M
FY2021-FY2025
Trend
+0.2%
vs FY2024
Sector context
#26 of 43
Health Care
What the data says
At $49M, Bio-Rad Laboratories's interest expense ranks #18 of 43 in the Health Care sector. Interest Expense has fluctuated over the past 10 years, ranging from $2M in FY2021 to $49M in FY2023.
Based on SEC 10-K filings.
$49M in FY2025 with a 5-year CAGR of +15.4%.
Remained stable around $49M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +8.7%
- 5-Year CAGR
- +15.4%
- 10-Year CAGR
- -
Sector benchmark
#18 of 43 in Health CareTop 40% of 43This company $49.0M Sector average $324.8M
▼
-84.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +15.4%, indicating consistent growth.
- In FY2025, interest expense increased 0.2% year-over-year.
- Ranks #26 out of 43 companies in the Health Care sector.
- Peak interest expense was recorded in FY2023.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $49.0M | +0.2% |
| FY2024 | $48.9M | -1.0% |
| FY2023 | $49.4M | +29.7% |
| FY2022 | $38.1M | +2356.5% |
| FY2021 | $1.6M | -93.5% |
| FY2020 | $24.0M | +2.3% |
| FY2019 | $23.4M | +0.2% |
| FY2018 | $23.4M | +7.8% |
| FY2017 | $21.7M | -2.0% |
| FY2016 | $22.1M | +2.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026